SCHEMBL853915

SCHEMBL853915

CCOC(=O)C=C(c1ccccc1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.35
MTNR1A P48039 4/20 0.35
MTNR1B P49286 4/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
POLB P06746 1/20 0.34
PIM1 P11309 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
LTA4H P09960 2/20 0.33
PLA2G2A P14555 2/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
SCN9A Q15858 1/20 0.31
F2 P00734 1/20 0.31
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854495 0.92 CCKBR (0.35) HTTMTNR1AMTNR1BMEN1KMT2A
SCHEMBL852464 0.86 NR4A2 (0.36) MTNR1AMTNR1BMEN1KMT2APIM1
SCHEMBL853670 0.80 NR1H2 (0.36) HTTMTNR1AMTNR1BMEN1KMT2A
SCHEMBL854074 0.78 ITGB3 (0.39) MEN1KMT2APPARGPPARDPPARA
SCHEMBL853983 0.76 ITGB3 (0.35) MTNR1AMTNR1BMEN1KMT2ATRPM8
SCHEMBL861190 0.74 MAOA (0.42) MTNR1AMTNR1BLTA4HPPARD
SCHEMBL853558 0.74 TRPM8 (0.55) MEN1KMT2ATRPM8POLBKDM4E
SCHEMBL853770 0.71 NR1H2 (0.36) MTNR1AMTNR1BMEN1KMT2ALTA4H
SCHEMBL860800 0.71 MAOB (0.35) MAPTPPARA
SCHEMBL6178941 0.70 PPARG (0.45) LTA4HPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed